210 related articles for article (PubMed ID: 22545169)
1. Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.
Martins MV; Guimarães MM; Spencer JS; Hacker MA; Costa LS; Carvalho FM; Geluk A; van der Ploeg-van Schip JJ; Pontes MA; Gonçalves HS; de Morais JP; Bandeira TJ; Pessolani MC; Brennan PJ; Pereira GM
PLoS Negl Trop Dis; 2012; 6(4):e1616. PubMed ID: 22545169
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
3. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.
Geluk A; Spencer JS; Bobosha K; Pessolani MC; Pereira GM; Banu S; Honoré N; Reece ST; MacDonald M; Sapkota BR; Ranjit C; Franken KL; Zewdie M; Aseffa A; Hussain R; Stefani MM; Cho SN; Oskam L; Brennan PJ; Dockrell HM;
Clin Vaccine Immunol; 2009 Mar; 16(3):352-9. PubMed ID: 19176694
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
Oliveira RM; Hungria EM; de Araújo Freitas A; de Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1415-24. PubMed ID: 24619112
[TBL] [Abstract][Full Text] [Related]
5. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.
Spencer JS; Dockrell HM; Kim HJ; Marques MA; Williams DL; Martins MV; Martins ML; Lima MC; Sarno EN; Pereira GM; Matos H; Fonseca LS; Sampaio EP; Ottenhoff TH; Geluk A; Cho SN; Stoker NG; Cole ST; Brennan PJ; Pessolani MC
J Immunol; 2005 Dec; 175(12):7930-8. PubMed ID: 16339528
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
[TBL] [Abstract][Full Text] [Related]
8. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.
Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manandhar R; Murillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
Infect Immun; 2000 Oct; 68(10):5846-55. PubMed ID: 10992494
[TBL] [Abstract][Full Text] [Related]
9. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
[TBL] [Abstract][Full Text] [Related]
10. T-cell recognition of peptides from the Mycobacterium leprae 35 kDa protein in Thai leprosy patients, healthy contacts, and non-contacts.
Chua-Intra B; Wattanapokayakit S; Srisungngam S; Srisungngam T; Mahotarn K; Brennan PJ; Ivanyi J
Immunol Lett; 2003 Jul; 88(1):71-6. PubMed ID: 12853165
[TBL] [Abstract][Full Text] [Related]
11. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
12. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
[TBL] [Abstract][Full Text] [Related]
13. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.
Geluk A; Klein MR; Franken KL; van Meijgaarden KE; Wieles B; Pereira KC; Bührer-Sékula S; Klatser PR; Brennan PJ; Spencer JS; Williams DL; Pessolani MC; Sampaio EP; Ottenhoff TH
Infect Immun; 2005 Sep; 73(9):5636-44. PubMed ID: 16113281
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease.
Sampaio EP; Moreira AL; Kaplan G; Alvim MF; Duppre NC; Miranda CF; Sarno EN
J Infect Dis; 1991 Nov; 164(5):990-3. PubMed ID: 1940481
[TBL] [Abstract][Full Text] [Related]
15. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
16. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
17.
Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
Front Immunol; 2018; 9():2920. PubMed ID: 30631322
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
19. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic assays for leprosy based on T-cell epitopes.
Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manadhar R; Murrillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
Lepr Rev; 2000 Dec; 71 Suppl():S55-8; discussion S58-9. PubMed ID: 11201888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
